Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

Share Price Information for Braveheart Investments (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 4.50
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 1.50 (33.333%)
Open: 5.25
High: 5.25
Low: 5.25
Prev. Close: 5.25
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further investment in Conjunct

20 Dec 2011 07:00

RNS Number : 2706U
Braveheart Investment Group plc
20 December 2011
 



20 December 2011

 

 

 

Braveheart Investment Group plc

 

Further investment in Conjunct Limited

 

 

Braveheart Investment Group (AIM: BRH) ('Braveheart' or the 'Group'), the AIM-listed specialist in growth capital investments for business angels, high net worth individuals and family offices, announces that it has led a third round of funding for its portfolio company Conjunct Limited. Investors in the c£340,000 round included the Group, Braveheart clients and Scottish Investment Bank's Scottish Co-investment Fund.

 

With the growth of the internet and an unprecedented demand for faster data transfer, fibre optic cabling is becoming mainstream, replacing traditional copper cables. To achieve faster connectivity within the fibre optic cable networks and support higher data rates, Conjunct has developed a highly innovative transceiver module, Fibre-Lyte. It is a novel packaging solution which can be applied to both datacoms and telecoms markets and has the potential to support data rates up to 300Gbps.

 

Conjunct, which is based in Livingston, central Scotland, has engaged with global organisations to integrate Fibre-Lyte into their product lines. The new money will be used to support Conjunct's production engineering activities for Fibre-Lyte manufacture and to complete development of a new Fibre-Lyte variant.

 

Geoffrey Thomson, Chief Executive of Braveheart, said: "Conjunct is now well placed to take advantage of the high demand for innovative optoelectronic solutions such as Fibre-Lyte and Conjunct is now in advanced discussions with the leading market players in optical systems."

 

Ken Allstaff, CEO of Conjunct, commented: "We are keen to move to the next stage of the Company's growth and are delighted to have again secured backing from Braveheart to allow us to offer Fibre-Lyte at costs and quantities which will enable continued market traction."

 

For further information please visit www.braveheartinvestmentgroup.co.uk and www.conjunct.co.uk or contact:

 

Braveheart Investment Group

Conjunct Limited

Geoffrey Thomson, Chief Executive

Ken Allstaff, Chief Executive

Tel: 01738 587555

Tel: 01506 465700

gthomson@braveheart-ventures.co.uk

ken.allstaff@conjunct.co.uk

 

 

Seymour Pierce Limited

Allerton Communications (for Braveheart)

Freddy Crossley (Nominated Adviser)

Peter Curtain

Paul Jewell / David Banks (Corporate broking)

Tel: 020 3137 2500

Tel: 020 7107 8000

peter.curtain@allertoncomms.co.uk

 

Notes to Editors

Braveheart Investment Group makes and manages investments in young, emerging British companies, specialising in building tax efficient portfolios for business angels, high net worth individuals and family offices. Braveheart was founded in 1997 by a small group of investors to encourage and syndicate investments in privately held companies that offered opportunities for significant growth. Fourteen years on, Braveheart is a public company with a demonstrable track record in technology investing, an established client base and various funds under management. The Group has offices in Perth, London, Yorkshire and Jersey with franchise operations in Dubai and Manchester.

 

Investments are made in unlisted companies where there is potential for significant growth through successful commercialisation of IP. Through close relationships with leading universities and innovation centres, Braveheart has access to a wide variety of emerging commercial opportunities at early stages. There are currently some 45 companies in Braveheart's diverse portfolio (includes all companies where the Group has a financial interest) and it has completed more than 90 deals.

 

Following the 2010 acquisition of Envestors Limited, the London based specialist corporate finance advisory business, Braveheart offers a unique and comprehensive suite of tax efficient products to high net worth investors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTLBFTMBMBBAB
Date   Source Headline
12th Nov 20087:00 amRNSSenior Management Change
16th Oct 20087:00 amRNSDirectorate Change
1st Oct 20087:00 amRNSTrading Statement
12th Sep 20084:43 pmRNSOffer Update
10th Sep 20082:27 pmRNSResult of AGM
4th Sep 200811:30 amRNSRule 8.3- Braveheart Inv. Grp
4th Sep 200811:22 amRNSRule 8.3- Braveheart Inv. Grp
26th Aug 200810:07 amRNSEPT Disclosure
21st Aug 20089:26 amRNSEPT Disclosure
18th Aug 20087:00 amRNSNotice of AGM & Directorate C
11th Aug 200810:26 amRNSEPT Disclosure
28th Jul 20087:00 amRNSGrant of Options
18th Jul 20083:09 pmRNSResponse RE Angle Offer
18th Jul 20087:00 amRNSStatement re possible offer
16th Jul 20089:17 amRNSEPT Disclosure
11th Jul 20081:05 pmRNSStatement re. announcement
11th Jul 20088:10 amRNSOffer Update
25th Jun 20087:00 amRNSPreliminary Results
23rd Jun 20081:58 pmRNSFurther re notice of results
23rd Jun 20087:01 amRNSCommercialisation Agreement
23rd Jun 20087:00 amRNSInvestment in IM-Sense
16th Jun 20087:00 amRNSNotice of Results
13th Jun 200812:27 pmRNSErnst and Young Award
5th Jun 20087:00 amRNSDirectorate Change
14th Apr 20087:00 amRNSInvestment in Spiral Gateway
10th Apr 200811:15 amRNSFurther re possible offer
10th Apr 20087:00 amRNSInvestment in Cascade
9th Apr 20084:24 pmRNSPossible Offer
7th Apr 20087:00 amRNSInvestment In Conjunct
2nd Apr 20087:01 amRNSInvestment in AppShare
13th Feb 20087:00 amRNSInvestment
8th Feb 20087:00 amRNSChange of Adviser
10th Jan 20087:00 amRNSInvestment
2nd Jan 20083:38 pmRNSChange of Adviser
3rd Dec 20077:00 amRNSInterim Results
21st Nov 20078:43 amRNSNotice of Results
1st Oct 20077:01 amRNSPortfolio Company Update
13th Sep 20077:05 amRNSResult of AGM
13th Sep 20077:01 amRNSDirectorate Change
20th Aug 20077:00 amRNSInvestment
17th Aug 20077:00 amRNSNotice of AGM/Annual Report
14th Aug 20077:00 amRNSAIM Rule 26
13th Aug 20077:00 amRNSInvestment
13th Jul 20077:00 amRNSAward of Options
19th Jun 20077:01 amRNSInvestment
18th Jun 20077:01 amRNSFinal Results
18th Jun 20077:00 amRNSFund Launch
14th Jun 20077:01 amRNSInvestment
8th Jun 20077:15 amRNSNotice of Results
4th Jun 200710:44 amRNSInvestee company flotation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.